Glycomimetics (GLYC) Posts Q1 Loss of 30c/Share

Glycomimetics (NASDAQ: GLYC) reported Q1 EPS of ($0.30), $0.01 worse than the analyst estimate of ($0.29).

For earnings history and earnings-related data on Glycomimetics (GLYC) click here.

You May Also Be Interested In

• Dollar Tree upgraded on earnings upside potential despite ongoing traffic woes
• SBC Medical Launches Japan's First Specialized Men's Beard Hair Removal Clinic, Introducing a Scalable, Capital-Efficient Growth Platform
• BMO Capital bullish on top pick Royal Caribbean as cruise tailwinds ’favorable’